SCHEMBL5836516

SCHEMBL5836516

CC(=O)N1c2ccc(F)cc2[C@@H](Nc2ccc(F)cc2)C[C@H]1C

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 6/20 0.72
▸ BRD2 P25440 3/20 0.72
▸ BRD3 Q15059 3/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17503238 1.00 BRD4 (0.72) BRD4BRD2BRD3
SCHEMBL5836512 1.00 BRD4 (0.72) BRD4BRD2BRD3
SCHEMBL17503239 1.00 BRD4 (0.72) BRD4BRD2BRD3
SCHEMBL224311 1.00 BRD4 (0.72) BRD4BRD2BRD3
SCHEMBL221888 0.92 BRD4 (0.73) BRD4BRD2BRD3
SCHEMBL2741188 0.92 BRD4 (0.68) BRD4BRD2BRD3
SCHEMBL13178434 0.91 BRD4 (0.65) BRD4BRD2BRD3
SCHEMBL221873 0.90 BRD4 (0.72) BRD4BRD2BRD3
SCHEMBL223302 0.89 BRD4 (0.61) BRD4BRD2BRD3
SCHEMBL222041 0.89 BRD4 (0.71) BRD4BRD2BRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3038621-B1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RES INSTITUTE (US) 2020-12-02 — — EP claimed
US-11596716-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2023-03-07 — — US disclosed
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2021-05-13 — — US disclosed
US-10874766-B2 Compounds and matrices for use in bone growth and repair HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2020-12-29 — — US disclosed
EP-3038621-B1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RES INSTITUTE (US) 2020-12-02 — — EP disclosed
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2016-02-11 — — US disclosed
US-7030246-B2 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof ASTRAZENECA AB (SE) 2006-04-18 — — US disclosed
US-20040132724-A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof ASTRAZENECA AB (SE) 2004-07-08 — — US disclosed
EP-1377553-A1 TETRAHYDROQUINOLINE DERIVATIVES AS STAT6-MODULATORS, PREPARATION AND USE THEREOF AstraZeneca AB (SE) 2004-01-07 — — EP disclosed
WO-2002079165-A1 TETRAHYDROQUINOLINE DERIVATIVES AS STAT6-MODULATORS, PREPARATION AND USE THEREOF ASTRAZENECA AB (SE) 2002-10-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10874766-B2 Compounds and matrices for use in bone growth and repair BMP2, BMP4, BMP6 BRD4 2279/4885BRD2 2362/4885BRD3 2435/4885
US-11596716-B2 Compounds and matrices for use in bone growth and repair BMP2, BMP4, BMP6 BRD4 2966/4885BRD2 3366/4885BRD3 3407/4885
US-20210138117-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 BRD4 2966/4885BRD2 3366/4885BRD3 3407/4885
US-20040132724-A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof STAT6, HRH4, HRH1 BRD4 39/4885BRD2 153/4885BRD3 85/4885
US-20160038641-A1 COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR BMP2, BMP4, BMP6 BRD4 1630/4885BRD2 2208/4885BRD3 2144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback